Roxadustat in CKD and transplant patients: A new era in anemia management
The aim of this study was to evaluate the efficacy and safety of Roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the management of anemia in patients with chronic kidney disease (CKD), including hemodialysis-dependent (HDD), non-dialysis-dependent (NDD), and renal...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Liaquat University of Medical and Health Sciences
2025-03-01
|
| Series: | Liaquat Medical Research Journal |
| Assuntos: | |
| Acceso en liña: | http://121.52.154.206/index.php/LMRJ/article/view/1284 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|